SGMT

NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.83

+0.98 (+9.95%)

As of Nov 14, 2:20 AM ET ·

SGMT News1 articles

Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial

Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.